|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/34 | |
| A61P 17/00 | |||
| A61P 17/16 | |||
| A61K 8/64 | |||
| A61Q 17/04 | |||
| A61Q 19/00 |
| (11) | Number of the document | 2865422 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14173509.2 |
| Date of filing the European patent application | 2007-08-31 | |
| (97) | Date of publication of the European application | 2015-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 2006904745 P | 2006-08-31 | AU | |
| 2007900862 P | 2007-02-21 | AU |
| (72) |
Wolgen, Philippe, AU
|
| (73) |
Clinuvel Pharmaceuticals Limited,
Level 6 / 15 Queen Street, Melbourne, VIC 3000,
AU
|
| (54) | Alpha-MSH derivatives for the treatment of photodermatoses |
| Alpha-MSH derivatives for the treatment of photodermatoses |